These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Mechanisms and pathways of innate immune activation and regulation in health and cancer. Cui J; Chen Y; Wang HY; Wang RF Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930 [TBL] [Abstract][Full Text] [Related]
16. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. O'Neill LA; Bowie AG Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343 [TBL] [Abstract][Full Text] [Related]
18. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095 [TBL] [Abstract][Full Text] [Related]
19. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391 [TBL] [Abstract][Full Text] [Related]
20. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]